Taiho Pharmaceuticals Co., Ltd. et al. v. Pharmascience Inc.
2024
T-1309-24
Pending
6(1) PMNOC
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,861,480; 2,914,999 and 2,985,006 (trifluridine/tipiracil).
Counsel to:
Pharmascience Inc.
The decision is reported
here.
Meet the team

Warren Sprigings
Partner
.jpg)
David Reive
Partner

Mingquan Zhang, Ph.D.
Associate

Meghan A. Dureen, Ph.D.
Counsel

Alexandre Lavoie
Associate

Raenaud Tiwari
Associate
.jpg)
Nancy You
Associate